1.What is pituitary adenoma? Pituitary adenoma is a benign tumor of the pituitary gland, with an incidence of about 1 in 100,000 in the population and an increasing trend in recent years. Pituitary adenoma not only causes vision loss, headache and other intracranial occupying signs, but also produces symptoms of endocrine disorders, such as infertility, amenorrhea, lactation, obesity and acromegaly. In serious cases, pituitary adenoma destabilizes the internal environment and even affects the external image of a social being. 2.What are the treatment options for pituitary adenoma? Comprehensive treatments for pituitary adenoma include surgery, general radiotherapy, r-knife stereotactic radiotherapy, medication, etc., while surgical treatments include open and transnasal butterfly. The correct choice of the above treatment methods or the combination of several methods is based on the following points: (1) The correct diagnosis of pituitary tumor or related saddle area lesions. (2) The size and shape of the pituitary tumor, the degree of invasion to the surrounding tissues, and the treatment history. (3) Judgment of the softness of the pituitary tumor by impact, tumor type, and medical history. (4) The patient’s age, physical condition, and whether he/she requires childbirth, etc. (5) What is the patient’s hormone level, whether there are systemic comorbidities and nasal lesions, etc. Systematic individualized treatment of pituitary tumors By “systematic individualized treatment”, we mean to adopt appropriate treatment plans for different types of pituitary tumors and each patient’s specific situation, and to conduct systematic long-term follow-up observation, so as to minimize the physical and psychological damage and maximize the quality of life of patients. For example, some patients can be treated with drug therapy alone or a combination of drug therapy and r-knife therapy; some patients can be followed up and observed regularly; most patients need to be treated with surgery, which has a definite effect. Postoperatively, it should be decided according to the specific situation of the patient whether radiotherapy or not, whether to combine with drug therapy, etc.; some patients need radiotherapy or drug therapy before transsphenoidal surgery in order to avoid the risk of craniotomy, which varies from person to person. In conclusion, it is particularly important to select the appropriate treatment plan for patients based on the above criteria for systematic individualized treatment.